UCLA School of Dentistry

Top Dental Practice, Torrance Dentistry, is Recognized as a 2023 Top Patient Rated Dentist by Find Local Doctors

Retrieved on: 
Monday, January 8, 2024
Dental implant, University, Dental care, UCLA, Multimedia, Physician, Dentist, Insurance, American Dental Association, UCLA School of Dentistry, Dental, Doctor, Patient, Sleep apnea, Dentistry

TORRANCE, Calif., Jan. 8, 2024 /PRNewswire-PRWeb/ -- Torrance Dentistry is a well-respected family dental practice that provides patients with exceptional service, whether they are coming in for a routine check-up, considering a cosmetic dental procedure or seeking specialized oral health care. The clinic's wide range of services ensures that all dental needs are met under one roof, and with periodontists on staff, advanced services can be offered right in the office for a convenient and comprehensive experience. Torrance Dentistry has been selected for this prestigious recognition as a result of the large number of five-star ratings and superior online reviews they have earned. Find Local Doctors provides a trusted online directory, helping patients easily locate qualified and reputable physicians and dentists in their area. The experienced Torrance Dentistry team offers full-service dentistry, including preventative and general dentistry, cosmetic options and restorative procedures, such as dental implants. The clinic's advanced technology and cutting-edge treatments help patients attain healthy, balanced and beautiful smiles. At Torrance Dentistry, they want to make it affordable and accessible for all patients to receive the dental care they need and accept many insurance plans and offer financing options.

Key Points: 
  • Torrance Dentistry has been selected for this prestigious recognition as a result of the large number of five-star ratings and superior online reviews they have earned.
  • Find Local Doctors provides a trusted online directory, helping patients easily locate qualified and reputable physicians and dentists in their area.
  • The experienced Torrance Dentistry team offers full-service dentistry, including preventative and general dentistry, cosmetic options and restorative procedures, such as dental implants .
  • He is a member of his local Western Dental Society, the California Dental Association and the American Dental Association.

UT Health San Antonio launches Center for Global and Community Oral Health

Retrieved on: 
Friday, December 1, 2023
School, Global health, Gingivitis, Health literacy, Research, Oral hygiene, SAN, Foreign policy, Canadian International Council, University, Dean (education), Workforce, Dentist, Plaque, History, Student, Patient, University of Texas System, Radioactive decay, Endocrine gland, UCLA School of Dentistry, MBA, MPH, Endodontics, Cancer, Pain, Doctor of Philosophy, Hospital, Diabetes, Periodontology, Education, Pharmaceutical industry, Nursing, Dentistry, DDS

SAN ANTONIO, Dec. 1, 2023 /PRNewswire-PRWeb/ -- The School of Dentistry of The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has launched the Center for Global and Community Oral Health, designed to bring together various existing outreach and research programs under one umbrella to study and develop solutions to the most pressing dental challenges facing the global population.

Key Points: 
  • New Center for Global and Community Oral Health at The University of Texas Health Science Center at San Antonio will address the world's most urgent dental challenges.
  • SAN ANTONIO, Dec. 1, 2023 /PRNewswire-PRWeb/ -- The School of Dentistry of The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has launched the Center for Global and Community Oral Health, designed to bring together various existing outreach and research programs under one umbrella to study and develop solutions to the most pressing dental challenges facing the global population.
  • To do this, Singh said the center will aim to increase access to oral health care to eliminate health disparities, integrate oral health care into medical care to prevent systemic disease and disseminate oral health information to increase health literacy with the ultimate goal of being a world leader in community oral health.
  • The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a primary driver of San Antonio's $44.1 billion health care and biosciences sector, is the largest academic research institution in South Texas with an annual research portfolio of more than $360 million.

DentaQuest Donates $30,000 to Marquette University School of Dentistry's Dental School Enrichment Program

Retrieved on: 
Monday, October 2, 2023
Marquette University School of Dentistry, Curriculum, UCLA School of Dentistry, Dentist, Student, Patient, School, Dental care, Knowledge, Sun Life Financial, Dentistry, Nursing

BOSTON, Oct. 2, 2023 /PRNewswire/ -- As part of an ongoing commitment to invest in the future dental workforce, DentaQuest, part of Sun Life U.S., is helping to increase access to oral health care by increasing the number of practicing dentists through its recent donation of $30,000 to Marquette University School of Dentistry (MUSoD). This donation was designated to support incoming students enrolled in its academic enrichment program for the school year that began this September. For DentaQuest, this donation is part of a larger investment effort to grow a diverse dental workforce around the country.

Key Points: 
  • This donation was designated to support incoming students enrolled in its academic enrichment program for the school year that began this September.
  • For DentaQuest, this donation is part of a larger investment effort to grow a diverse dental workforce around the country.
  • Specifically, this contribution supports MUSoD's Dental School Enrichment Program (DSEP), a five-week curriculum designed to reinforce skills and prepare incoming students for success with MUSoD's rigorous four-year curriculum.
  • Since 1996, the summer enrichment program has made a difference for 200 MUSoD graduates who otherwise would not have been accepted into the four-year dental degree program.

Skoulas DDS - The SF Cosmetic Dentist of San Francisco Announces New Website

Retrieved on: 
Tuesday, September 26, 2023
American Dental Association, Dental assistant, Dental implant, Cosmetic dentistry, Academy of General Dentistry, Twilight anesthesia, IV, American Academy of Cosmetic Dentistry, UCLA School of Dentistry, American Academy, Blog, Patient, SAN, DDS, Dental care, Health, Postgraduate training in general dentistry, Dental, Commerce, Online shopping, Dentistry

SAN FRANCISCO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- Skoulas DDS - The SF Cosmetic Dentist, a premier dental clinic in San Francisco, CA, is pleased to announce the launch of a new and enhanced website at https://www.skoulasdds.com. The new website offers a streamlined design and user experience, making it easier to find the information that you need. It also has a variety of new features, including a more user-friendly design, a list of services offered, a blog, and more relevant content.

Key Points: 
  • Skoulas DDS - The SF Cosmetic Dentist, a premier dental clinic in San Francisco, CA, is pleased to announce the launch of a new and enhanced website at https://www.skoulasdds.com .
  • SAN FRANCISCO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- Skoulas DDS - The SF Cosmetic Dentist, a premier dental clinic in San Francisco, CA, is pleased to announce the launch of a new and enhanced website at https://www.skoulasdds.com .
  • Skoulas DDS - The SF Cosmetic Dentist is a highly awarded dental practice that specializes in cosmetic dentistry and advanced dental care.
  • Services provided by Skoulas DDS - The SF Cosmetic Dentist include:
    Sedation dentistry: Dental sedation, conscious sedation, and IV anesthesia for dental procedures.

Innova Vascular Earns FDA Clearance for Two New Thrombectomy Devices: Laguna Clot Retriever™ System and Malibu Aspiration Catheter™ System

Retrieved on: 
Wednesday, June 7, 2023
Innova, UCLA School of Dentistry, Food and Drug Administration, David Geffen School of Medicine at UCLA, Blood, Thrombectomy, Patient, Malibu, Thrombus, Nickel titanium, System, Aspiration, FDA, Massachusetts General Hospital, Embolism, Food, Medical imaging, Medicine

The two new devices are collectively known as the Laguna Thrombectomy System.

Key Points: 
  • The two new devices are collectively known as the Laguna Thrombectomy System.
  • The Malibu Aspiration Catheter System offers excellent navigability and ease of use, with the ability for operators of all skill levels to remove clots efficiently.
  • "The Laguna Thrombectomy System offers an innovative solution to treat a wide range of clots in the peripheral vasculature."
  • The System offers a comprehensive range of sizes of the Malibu Aspiration Catheter as well as the Laguna Clot Retriever.

Torrance Dentist Dr. Adriana Barrera of Barrera Advanced Dentistry is Selected as a 2023 Top Patient Rated Dentist by Find Local Doctors

Retrieved on: 
Monday, April 3, 2023
Linda, American Dental Association, Madison Street, Doctor, UCLA School of Dentistry, Dental implant, Loma Linda University, California Dental Association, Suite, Dentist, Trust, Patient, Physician, Prosthodontics, Pontifical Xavierian University, Dentistry

TORRANCE , Calif., April 3, 2023 /PRNewswire-PRWeb/ -- As a result of the superior ratings and exceptional online reviews the clinic has received from satisfied patients, Find Local Doctors has recognized Dr. Adriana Barrera and her team at Barrera Advanced Dentistry in Torrance, California, with this prestigious award. This well-respected clinic is among the premier group of dental practices to earn this designation. Find Local Doctors is a trusted online directory that helps consumers easily locate qualified physicians and dentists in their area. Dr. Adriana Barrera has been treating patients for over 20 years, delivering advanced, comprehensive dentistry to countless patients and families. With her extensive training and clinical experience, she is proud to offer the most advanced dental treatments and procedures spanning all facets of preventive, restorative and cosmetic dentistry. Dr. Barrera and her dental staff are passionate about helping patients smile, by meeting dental goals through the clinic's many services such as routine cleanings, gum disease treatments, dental implants, oral surgery and more. Barrera Advanced Dentistry welcomes patients to an inviting and friendly atmosphere that focuses on modern dentistry that is comfortable, safe and affordable.

Key Points: 
  • TORRANCE , Calif., April 3, 2023 /PRNewswire-PRWeb/ -- As a result of the superior ratings and exceptional online reviews the clinic has received from satisfied patients, Find Local Doctors has recognized Dr. Adriana Barrera and her team at Barrera Advanced Dentistry in Torrance , California, with this prestigious award.
  • Find Local Doctors is a trusted online directory that helps consumers easily locate qualified physicians and dentists in their area.
  • Dr. Adriana Barrera has been treating patients for over 20 years, delivering advanced, comprehensive dentistry to countless patients and families.
  • Barrera Advanced Dentistry welcomes patients to an inviting and friendly atmosphere that focuses on modern dentistry that is comfortable, safe and affordable.

WesternU College of Podiatric Medicine celebrates 100% match rate for 10 consecutive years

Retrieved on: 
Thursday, March 23, 2023
Yee, Faculty, Perseverance, University, Camara, Western University College of Podiatric Medicine, Education, Friends, Jacob Labovitz, UCLA School of Dentistry, Tears, RCPS, Mentorship, Veterans Health Administration, Western University of Health Sciences, FACPM, Student, DPM, UCLA School of Nursing, Nursing, Outline of health sciences, CPM, Scripps Mercy Hospital, UCLA, FFPM, Family, Buster Guzzardo, Podiatry, Dentistry, Tourism, Western University

POMONA, Calif., March 23, 2023 /PRNewswire-PRWeb/ -- For graduating medical students in Western University of Health Sciences' College of Podiatric Medicine (CPM), Match Day is a transformative, life-changing moment. The anxiety-filled day begins with reflections of personal endurance, hard work and self-sacrifice that instantly changes to excitement, joy and smiles learning that their journey at WesternU has made their dream come true: becoming a physician.

Key Points: 
  • POMONA, Calif., March 23, 2023 /PRNewswire-PRWeb/ -- For graduating medical students in Western University of Health Sciences' College of Podiatric Medicine (CPM), Match Day is a transformative, life-changing moment.
  • Since 1976, the Central Application Service for Podiatric Residencies has coordinated this annual rite of passage for podiatric medical and surgical residencies.
  • CPM continues to keep its promise of leading the way in inspiring and preparing the next generation of podiatric physicians.
  • In a moment of reflection, College of Podiatric Medicine Dean Jonathan Labovitz, DPM, FACFAS, CHCQM, thought about the bigger picture of this accomplishment.

Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

Retrieved on: 
Tuesday, March 14, 2023
UCLA School of Dentistry, Acquisition, UCLA, Therapy, Division, Dimension, Partnership, Mentorship, David Geffen School of Medicine at UCLA, Gene, Genetics, Haemophilia, Patient, Pediatrics, Biology, Metabolism, Rare, DSM-IV codes, University, CMO, Disease, Wayne State University School of Medicine, Medical genetics, OTC, Pharmaceutical industry, Nursing, Ultragenyx

NOVATO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that Eric Crombez, M.D., has been promoted to chief medical officer and executive vice president effective May 1, 2023, succeeding Camille Bedrosian, M.D., who will remain with the company in a full-time strategic advisory role.

Key Points: 
  • NOVATO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that Eric Crombez, M.D., has been promoted to chief medical officer and executive vice president effective May 1, 2023, succeeding Camille Bedrosian, M.D., who will remain with the company in a full-time strategic advisory role.
  • Dr. Crombez currently serves as Ultragenyx’s chief medical officer for gene therapy and inborn errors of metabolism.
  • “Eric has extensive expertise in the development and execution of clinical development programs for rare genetic disorders and has been a driving force for our entire gene therapy pipeline,” said Emil D. Kakkis, M.D., Ph.D., chief executive officer and president of Ultragenyx.
  • Dr. Crombez joined Ultragenyx following the acquisition of Dimension Therapeutics in November 2017.

Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer  

Retrieved on: 
Tuesday, February 28, 2023
Stanford University School of Medicine, Pediatrics, Therapy, Loyola University, Cancer, University, Transplant, Associate, Baylor College of Medicine, Martin Shkreli, Spacecraft, Drug development, University of Illinois Urbana-Champaign, Pediatric Hematology and Oncology, Baylor University, Patient, Trial of the century, UCLA School of Dentistry, STRO, SAN, Exelixis, David Geffen School of Medicine at UCLA, Jazz Pharmaceuticals, Abbott Laboratories, Pharmaceutical industry, Medicine, Hematology, Biochemistry, Curie Institute (Paris)

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the appointment of Anne Borgman, M.D., as Chief Medical Officer, effective February 28, 2023.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the appointment of Anne Borgman, M.D., as Chief Medical Officer, effective February 28, 2023.
  • Dr. Borgman brings over 20 years of oncology and hematology drug development experience to Sutro, including extensive regulatory experience in both the U.S. and Europe, leading to nine regulatory approvals.
  • “We are thrilled to welcome Dr. Borgman, whose expertise in developing targeted oncology drugs, makes her an ideal addition to our executive team,” said Bill Newell, Sutro’s Chief Executive Officer.
  • In addition, Sutro has executed meaningful relationships with global pharmaceutical partners,” said Dr. Borgman.

KalVista Pharmaceuticals Presents Data at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

Retrieved on: 
Monday, February 27, 2023
Health, Other Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, KALV, University, University of Cincinnati, Anxiety, Annual general meeting, Parenteral Drug Association, Howard University Hospital, Hereditary angioedema, Critical care, UCLA School of Dentistry, AAAAI, Demand valve oxygen therapy, Division, HAE, University of Cincinnati Academic Health Center, David Geffen School of Medicine at UCLA, FAERS, Duke University Hospital, Tablet, OH, American Academy, Pharmaceutical industry, Medical device, Immunology

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today presented five posters at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San Antonio, Texas.

Key Points: 
  • KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today presented five posters at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San Antonio, Texas.
  • The following presentations occurred at the 2023 AAAAI Annual Meeting:
    A comparative bioavailability of sebetralstat following administration of orally disintegrating tablets and film-coated tablets in healthy volunteers: Michael D. Smith, KalVista Pharmaceuticals Inc., Cambridge, MA, USA
    Reporting of Adverse Drug Reactions with Parenteral Drugs for the On-Demand Treatment of Hereditary Angioedema Attacks – Analysis of the FAERS Database 2009 to 2022: Dr. Raffi Tachdjian, UCLA School of Medicine, Los Angeles, CA, USA
    Anxiety Associated With Parenteral On-Demand Treatment For Hereditary Angioedema (HAE): Dr.
  • Autumn Burnette, Division of Allergy and Immunology, Howard University Hospital, Washington, DC, USA
    Patient Perspectives On Early Use Of On-Demand Treatment For Hereditary Angioedema (HAE) Attacks to Reduce Severity and Duration: Dr. Cristine Radojicic, Division of Pulmonary, Allergy and Critical Care, Duke University Medical Center, Durham, North Carolina, USA
    Treatment with Sebetralstat Reduces the Cumulative Symptom Severity of Hereditary Angioedema Attacks in a Phase 2 Trial: Dr. Jonathan A. Bernstein, University of Cincinnati College of Medicine and Bernstein Clinical Research Center, LLC, Cincinnati, OH, USA
    “The real-world data presented at AAAAI highlight the significant treatment burden and anxiety associated with existing injectable on-demand therapies, and the potential for sebetralstat, an investigational oral plasma kallikrein inhibitor, to improve the treatment experience for people living with HAE,” said Andrew Crockett, Chief Executive Officer of KalVista.
  • “Additionally highlighting this potential are the data from our phase 2 trial assessing sebetralstat for on-demand of HAE attacks demonstrating that early treatment decreased cumulative attack and symptom severity compared to placebo, as well as new data supporting continued advancement of our orally disintegrating tablet formulation.”